A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)
Conditions: Candidiasis, Esophageal; Candidiasis, Invasive; AspergillosisIntervention: Drug: CaspofunginSponsor: Merck Sharp & Dohme Corp.Completed - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials